Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Triple negative breast cancer: what clinical progress have we seen in the last 5?years?
Advanced Triple-Negative Breast Cancer: Emerging Therapies and a Changing Treatment Landscape.
Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer.
Decrease in Incidence of Young-Onset Colorectal Cancer Before Recent Increase.
Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized Approach.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized Approach.
Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized Approach. Am Soc Clin Oncol Educ Book. 2026 Jun; 46(3):e520666.
View in:
PubMed
subject areas
Biomarkers, Tumor
Female
Humans
Neoplasm Staging
Precision Medicine
Triple Negative Breast Neoplasms
authors with profiles
Rita Nanda